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Amber J. McCartney1)y, Yanling Zhang2)y and Lois S. Weisman1)2)3)

Recent studies of the low abundant signaling lipid,
phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2), reveal
an intriguingly diverse list of downstream pathways, the
intertwined relationship between PI(3,5)P2 and PI5P, as
well as links to neurodegenerative diseases. Derived from
the structural lipid phosphatidylinositol, PI(3,5)P2 is
dynamically generated on multiple cellular compartments
where interactions with an increasing list of effectors
regulate many cellular pathways. A complex of proteins
that includes Fab1/PIKfyve, Vac14, and Fig4/Sac3 medi-
ates the biosynthesis of PI(3,5)P2, and mutations that
disrupt complex function and/or formation cause profound
consequences in cells. Surprisingly, mutations in this
pathway are linked with neurological diseases, including
Charcot-Marie-Tooth syndrome and amyotrophic lateral
sclerosis. Future studies of PI(3,5)P2 and PI5P are likely to
expand the roles of these lipids in regulation of cellular
functions, aswell as provide new approaches for treatment
of some neurological diseases.
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Introduction
Phosphorylated phosphatidylinositol (PIP) signaling lipids
play regulatory roles. These low-abundance lipids are
produced from phosphatidylinositol (PI), an abundant
structural component of membranes, which can be phos-
phorylated in any combination on positions three, four, or
five. Highly regulated PIP kinases and phosphatases generate
and turn over the resultant seven PIP lipids (Fig. 1).
PIP lipids provide spatial and temporal regulation of
complex protein machines. The interconvertibility of PIPs
enables rapid changes in the identity of the signaling lipid to
dynamically recruit effector proteins to specific membranes at
the right time. For example, synthesis of phosphatidylinositol
3-phosphate (PI3P) [1] at a confined region is predicted to
assemble a large complex of multiple PI3P binding proteins
and their associated binding partners. Notably, the lipid
kinase, Fab1, binds PI3P [2] (Fig. 2) and catalyzes the
conversion of PI3P to phosphatidylinositol 3,5-bisphosphate
(PI(3,5)P2) [1]. Recruitment of Fab1 causes local depletion of
PI3P and an increase in the levels of PI(3,5)P2, which releases
PI3P binding proteins and recruits a distinct set of PI(3,5)P2
binding proteins.
Since the discovery of PI(3,5)P2 in 1997 [3, 4], the number
of known PI(3,5)P2 regulated pathways has expanded greatly.
Identification of a comprehensive list of these pathways
and downstream effector proteins will be required to fully
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understand PI(3,5)P2 signaling. Similarly, stimuli that regulate
PI(3,5)P2 levels remain to be identified. Here, we assess current
knowledge and suggest future directions for the study of this
very low abundance lipid.
PI(3,5)P2 is much less abundant than most PIPs, including
PI4P and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2).
PI(3,5)P2 is present at about 0.1 and 0.04% of total PI in
yeast andmammalian fibroblasts, respectively. The amount of
PI(3,5)P2 is 17- and 125-fold less abundant than PI(4,5)P2 in
yeast [5] and mammalian fibroblasts [6], respectively. The
scarcity of PI(3,5)P2 likely contributed to the 25 year delay in its
discovery [3, 4] relative to PI4P and PI(4,5)P2 [7]. Utilizing
dilute perchloric acid to precipitate cells followed by
deacylation of lipids significantly improved the yield of
glycerol-inositol head-groups and the identification of PI(3,5)
P2 over the traditional Folch extraction [4, 5].
Synthesis and turnover of PI(3,5)P2 is
tightly controlled by a large protein
complex
In yeast, Fab1 [8] is the sole PI3P 5-kinase [1, 9] and
Vps34 is the sole PI 3-kinase [10]. Both PI(3,5)P2 and
PI3P levels dynamically and transiently change in response
to specific stimuli. Prolonged introduction of yeast into
hyperosmotic media causes a 20-fold transient elevation of
PI(3,5)P2 [3] that lasts for about ten minutes before a
precipitous drop to basal levels [11]. Concomitant with the
rise in PI(3,5)P2, synthesis of PI3P increases. These data
suggest that PI(3,5)P2 and PI3P play early roles in adaptation
of yeast to hyperosmotic stress. Similarly, these lipids may
regulate adaptation in plants and animals, such as transient
responses to hormonal or sensory stimuli.
Fab1, commonly called PIKfyve in mammals, is present
in most eukaryotes [12]. In this paper, “Fab1” refers to Fab1
in all non-mammalian species and “PIKfyve” to mammals.
“Fab1/PIKfyve” refers to themammalian and non-mammalian
enzyme. In yeast and mouse embryonic fibroblasts (MEF),
Fab1/PIKfyve provides all of the PI(3,5)P2 [1, 6, 9, 13–18].
Across species, the domain structure is similar (Fig. 2).
The PI(3,5)P2 synthesis complex
The dynamic and rapid changes in PI(3,5)P2 observed in yeast
suggests that Fab1 is tightly regulated. Moreover, over-
expression of Fab1 does not increase PI(3,5)P2 levels in
yeast [1]. Indeed, Fab1 activity requires formation of a complex
of regulatory proteins, including Fig4, Vac14, Vac7, and Atg18.
Fig4, a PI(3,5)P2 5-phosphatase, catalyzes the turnover
of PI(3,5)P2 in yeast [11, 19–21]. Unexpectedly, Fig4 is also
required for the activation of Fab1/PIKfyve [6, 11, 19, 22].
Mutations in the catalytic site of Fig4 negatively affect both the
turnover of PI(3,5)P2 and the elevation in PI(3,5)P2 in response
to hyperosmotic stress [19]. In addition to Fig4 catalytic
activity, other regions in Fig4 may play a role. Several disease
mutations in Fig4 reside in a non-catalytic, N-terminal
domain [23]. Analysis of a corresponding mutation (Fig4-
I59T) in yeast revealed a defect in hyperosmotic shock induced
activation of Fab1 [22]. Analysis of this N-terminal domainmay
provide insight into how Fig4 activates Fab1/PIKfyve.
Figure 1. Interconversion among the seven
known phosphoinositide lipids occurs via action
of specific lipid kinases (red arrows) and phos-
phatases (blue arrows). Selected kinases and
phosphatases are shown. While controversial,
direct conversion of PI to PI5P via PIKfyve
activity may contribute to the PI5P pool (gray
arrows). INPP4A phosphatase, which causes
neurodegeneration in mice [118], and the type II
PI5P 4-kinase [119, 120], which has a role in
the regulation of PI5P levels, were not discussed
in this paper.
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Vac14 regulates both Fab1 and Fig4 [5, 24]
and is required for the synthesis and
turnover of PI(3,5)P2 [11]. Vac14, composed
of virtually all HEAT repeats (Fig. 2),
functions as a scaffold protein that nucle-
ates the formation of a complex including
Fab1, Fig4, and other regulators [25, 26]
(Fig. 3). Vac14 forms dimers or oligom-
ers [24–27]. In the cytoplasm, Fig4 and
Vac14 interact without Fab1 [25]. There may
be additional proteins required to form the
complex.
Similarly, mammalian Vac14 (ArPIK-
fyve) forms a complex with PIKfyve, and
Fig4 (Sac3) [26, 28–31]. The interaction
sites between the yeast and mammalian
complexes are likely conserved. The bind-
ing site for Fab1 on Vac14 is conserved in
the mammalian complex [26, 28]. Fig4
binds to Vac14 through the conserved C-
Figure 2. Fab1/PIKfyve, Vac14, and Fig4 are conserved in most eukaryotes. Domains of
S. cerevisiae and human Fab1/PIKfyve, Vac14, and Fig4/Sac3 are shown. A: Fab1
domains include FYVE (binds PI3P), DEP (unknown function; present in chordate and
insect Fab1), CCT (homologous to the chaperone Cpn60/TCP-1 family; mediates
interactions with Vac14), CCR (a conserved cysteine rich domain found only in Fab1/
PIKfyve; part of the Vac14 binding region), kinase (catalytic site for conversion of PI3P to
PI(3,5)P2). B: Vac14 is composed of tandem HEAT repeats, which are rod-like helical
structures that mediate protein-protein interactions. C: Fig4 contains a Sac domain,
which is a module found in several lipid phosphatases. Note, the number of amino acids
in mouse PIKfyve and human PIKfyve are not identical. The catalytically impaired mutation
in mouse PIKfyve, K1831E, is indicated on the schematic of human PIKfyve, K1877E.
The boundaries for FYVE, CCT, CCR, kinase, and Sac domains were identified as
follows: (1) conserved in multiple sequence alignments and (2) contained unbroken
secondary structure elements predicted by the program Jpred. Sequences for Fab1/
PIKfyve were from the following species: Saccharomyces cerevisiae (budding yeast,
NP_116674), Schizosaccharomyces pombe (fission yeast, NP_596090), Candida albicans
(human pathogen, CAC42810), Ashbya gossypii (cotton pathogen, NP_985045), Arabi-
dopsis thaliana (plant, NP_001078484), Drosophila melanogaster (fly, NP_611269), Apis
mellifera (honey bee, XP_393666), Anopheles gambiae (mosquito, XP_314118), Caeno-
rhabditis elegans (worm, CAA19436), and Homo sapiens (human, NP_055855). The Sac
domain in Fig4 was defined through alignment of the following Sac domain proteins in
S. cerevisiae: Inp51, Inp52, Inp53, Sac1, and Fig4.
A. J. McCartney et al. Prospects & Overviews....
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terminal region [28]. Additionally, the N-terminal pathogenic
point mutation, Fig4-I41T, disrupts the interaction of Fig4
with Vac14 and destabilizes Fig4 [29, 32]. These observations
raise the possibility that both the N- and C-termini of Fig4
interact with Vac14.
Yeast Vac7, a critical activator of Fab1, has no recognizable
motifs; its mode of action is unknown [1, 5, 11, 19, 20, 33]. Vac7
resides within the Fab1 complex, but is not required for
formation or localization of the complex [1, 21, 26]. This is
surprising because Vac7 is the only protein in the complex
with a transmembrane domain [5]. Vac7 function is likely
conserved in metazoans. However, based on sequence
similarity, Vac7 is only present in some fungi. Either,
alternative mechanisms activate Fab1/PIKfyve in metazoans,
or proteins with functions analogous to Vac7 cannot be
identified by BLAST search.
Yeast Atg18, a negative regulator of PI(3,5)P2 levels,
resides within the Fab1 complex. Through two adjacent
binding sites [34–36], Atg18 binds to PI(3,5)P2 and PI3P [37].
These sites are essential for Atg18 to negatively regulate
PI(3,5)P2 levels and for localization of Atg18 on the
vacuole [38]. Relief of Fab1 inhibition in an atg18D strain
requires Fab1 activators. Thus, Atg18 likely inhibits the
activators rather than acting on Fab1 directly. Metazoans may
have unidentified proteins that function similarly to yeast
Atg18. The mammalian genes, WIPI1,
WIPI2, WIPI3, and WIPI4, encode proteins
with greater than 20% identity to yeast
Atg18 [15, 39]. WIPI1 and WIPI2, like Atg18,
function in autophagy. However, whether
they function as negative regulators of
PI(3,5)P2 levels has not been tested.
Orchestrating Fab1/PIKfyve activity
At least three mechanisms within the
Fab1 complex contribute to the dynamic
regulation of PI(3,5)P2. First, the lipid
kinase and phosphatase reside within
the complex. Second, the Fab1 activator,
Vac7, and inhibitor, Atg18, bind overlap-
ping sites on Vac14 and likely compete for
access to Fab1. Third, catalytic activity of
Fig4 is required for the activation of
Fab1. Tight coordination between synthesis
and turnover of PI(3,5)P2 likely explains
how a sustained stimulus of hyperosmotic
shock causes a steep transient increase in
PI(3,5)P2 levels.
Other opposing lipid kinases and
phosphatases reside in the same complex
or have coordinated regulation (reviewed
in [40]). MTM1, a lipid 3-phosphatase,
resides in a complex with the PI3-kinase,
Vps34. Inositol polyphosphate 4-phospha-
tase is in a complex with a class I PI3-
kinase. The added complexity in the Fab1
complex, that the opposing lipid phospha-
tase has a second role as activator of the
lipid kinase, underscores the importance of
directly measuring phosphoinositide lipid levels to determine
cellular functions of predicted lipid phosphatases.
Comparison of PI(3,5)P2 synthesis in yeast and metazoans
In metazoans, several PI 3-kinases, in addition to Vps34,
may produce the PIKfyve substrate, PI3P. Indeed,
knockdown of either PIKfyve or PI3K-C2a, but not Vps34,
affects TORC1 activity in adipocytes [41]. Thus, in some cases
PI3K-C2a may provide the pool of PI3P utilized to generate
PI(3,5)P2.
A major difference between the yeast and mammalian
Fab1/PIKfyve complex are the lipid pools that they control.
Surprisingly, in MEF cells the PIKfyve complex is required for
most of the phosphatidylinositol 5-phosphate (PI5P) and all of
the PI(3,5)P2 pool [6, 14, 17, 42]. An independent study
concluded that PIKfyve does not contribute to PI5P levels [43];
however, that study assumed that PIKfyve inhibition did not
impact the lipids used to standardize the samples.
The relative importance of Vac14 for Fab1/PIKfyve
activity differs between the yeast and mammalian complexes.
In vac14D yeast, PI(3,5)P2 levels are reduced at least 10-fold
[11, 19], while Vac14/ and Fig4/ MEF cells reveal a more
modest 2-fold reduction in PI(3,5)P2 and PI5P [6, 22, 42]. Since
Vac14 or Fig4 are required for only half of the PI(3,5)P2 pool
Fab1/
PIKfyveAtg18
Vac7
Stimuli
Vac14
PI3P PI(3,5)P2
*
Fig4/Sac3
*
▼
▼
lipid kinase
lipid phosphatase
PI5P
L156R (ingls)
H56Y, R61K, Q101R
I41T
MTMRs
activator
inhibitor
CCT
CCR
*▼▼
Figure 3. Schematic of the Fab1/PIKfyve, Vac14, Fig4/Sac3 complex. Vac14 oligomer-
izes with itself and nucleates the complex through direct interactions with Fab1/PIKfyve
and Fig4/Sac3. In yeast, Vac14 also directly interacts with Atg18 and Vac7. The yeast
Vac14 point mutants, H56Y (HEAT repeat loop 2), R61K (HEAT repeat loop 2), and
Q101R (HEAT repeats loop 3), each disrupt binding of Atg18 and Vac7. Thus, Atg18 and
Vac7 may bind overlapping or identical sites of Vac14 [26]. The Vac14-L156R mutation,
found in ingls mice, and corresponding mutation Vac14-L149R in yeast, disrupts Vac14
interaction with Atg18, Vac7, and Fab1. This suggests that all three proteins bind
overlapping sites on Vac14. The point mutation, Fig4-I41T found in patients with CMT4J,
disrupts the interaction between Fig4 and Vac14, although the major portion of human
Fig4 that interacts with Vac14 resides within residues 478–907 [28]. In mammalian cells,
myotubularin related proteins (MTMRs) can convert PI(3,5)P2 to PI5P and may provide
the majority of cellular PI5P.
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and PIKfyve is required for the entire pool, PIKfyve either
retains partial function in the absence of Vac14 or Fig4 and/or
PIKfyve has additional regulators.
Localization of Vac14, Fab1/PIKfyve, and Fig4
In yeast, Fab1, Vac14, Fig4 are found on the limiting
membrane of vacuoles and adjacent foci, which are likely
endosomes [21, 25, 26]. In metazoan cells, Fab1/PIKfyve and
Vac14 are found on early and late endosomes, lysosomes, and
in the cytosol [44–50]. Questions remain about how the
complex is associated with membranes. Is the FYVE domain
of Fab1/PIKfyve sufficient for localization of the complex?
Are there other lipid-binding or transmembrane containing
subunit(s)?
PI(3,5)P2 is a precursor for PI5P synthesis
PI(3,5)P2 likely serves as a precursor for most of the cellular
PI5P pool. The strongest evidence for this hypothesis comes
from heterologous expression of PIKfyve in yeast, which
greatly increases PI(3,5)P2 and decreases its precursor, PI3P.
Importantly, the combined total of PI3P, PI5P, and PI(3,5)P2
remains constant in the presence or absence of heterologous
PIKfyve [6]. If PI5P were generated directly by PIKfyve, then
new direct conversion of PI to PI5P would raise the combined
total of PI3P, PI5P, and PI(3,5)P2. Additionally, transient
activation or inhibition of endogenous PIKfyve in fibroblasts,
causes PI(3,5)P2 levels to reach a new steady-state faster
than PI5P, an outcome consistent with a precursor-product
relationship [6].
Generation of PI5P from PI(3,5)P2 requires proteins with
3-phosphatase activity [6], which may be provided by
myotubularins (MTMRs) [51]. Indeed, mouse MTMR2 and
DrosophilaMTMR3 function with Fab1/PIKfyve to control PI5P
and PI(3,5)P2 [52, 53]. That both PI(3,5)P2 and PI5P are
embedded in membranes, and cannot freely diffuse, raises the
possibility that MTMRs reside within the PIKfyve complex.
This would provide rapid access of MTMRs to the newly
synthesized PI(3,5)P2.
An alternative hypothesis, that PIKfyve directly gen-
erates most of the cellular PI5P, has been recently
reviewed [54]. Briefly, there is controversy between
independent in vitro studies about whether PIKfyve
directly generates PI5P [12]. In some studies PIKfyve was
immunoprecipitated from cells that express many lipid
3-phosphatases. Tight association of PIKfyve with
3-phosphatases during immunoprecipitation may explain
some discrepancies. Strong in vitro evidence that PIKfyve
can directly generate PI5P comes from studies of PIKfyve
expressed from insect Sf9 cells [55]. Development of a
general inhibitor of myotubularin function may help resolve
whether most of the cellular PI5P pools are generated
directly or indirectly by PIKfyve.
That PIKfyve is either directly or indirectly responsible for
most of the PI5P in fibroblasts raises questions about whether
PI(3,5)P2 and PI5P reside on the same membrane. Localization
of Vac14, Fab1/PIKfyve, and Fig4 provide insights into the
subcellular locations of PI(3,5)P2 in yeast and metazoans. If
MTMRs are associated with this complex, then MTMR
localization would provide information for the subcellular
distribution of PI5P as well (Fig. 4A). However, the presence of
Vac14, Fab1/PIKfyve, and Fig4 does not a priori indicate
enzymatic activity. Thus, development of lipid probes will be
critical to determine the spatial and temporal dynamics of
PI(3,5)P2 and PI5P.
PI(3,5)P2 binding proteins
Based on the pleiotropic defects observed in cells and
organisms with defects in PIKfyve activity, most PI(3,5)P2
binding proteins are likely not yet identified. To date, multiple
types of motifs as well as novel sequences have been shown to
interact with PI(3,5)P2. PI(3,5)P2 binds directly to some WD40
domain containing proteins, including Atg18, Atg21, Hsv2,
Tup1 (in yeast), and Raptor (in adipocytes), and regulates their
functions in vivo [37, 41, 56]. Additionally, sorting nexin
proteins, SNX1 and SNX2 (PX domain) [57, 58], Cti6 (PHD
domain) [56], clavesin (Sec14 domain) [59], and class II
formins (PTEN domain) [60] interact with PI(3,5)P2. TRPML1
and RyR1 also bind PI(3,5)P2 [61, 62]. In these latter examples,
no lipid binding motif is apparent. Thus, bioinformatic
approaches are not sufficient to determine which proteins
bind PI(3,5)P2.
Atg18 binds PI(3,5)P2 with a high affinity, in the nano-
molar range [37], likely due to tandem lipid binding sites.
Lower affinity interactions may be of equal biological
significance but are more difficult to detect. Moreover, some
effectors require simultaneous interactions with other pro-
teins (reviewed in [63]). For example, the FYVE domain
containing protein, EEA1, associates with membranes via
simultaneous interaction with PI3P and Rab5 GTPase. The
development of strategies to detect relatively low affinity
binding will be necessary to identify the full set of PI(3,5)P2
and PI5P effectors.
Pathways regulated by Vac14,
Fab1/PIKfyve, and Fig4
Mutants deficient in Fab1 or its regulators provide information
on its cellular (Table 1) and physiological roles (Table 2). The
PIKfyve inhibitors, YM201636 and MF4, have also facilitated
studies of cellular functions of PIKfyve [13, 64]. However, off-
target effects need to be considered [65].
In mammals, loss of PIKfyve function decreases both
PI(3,5)P2 and PI5P [6, 14, 42], thus phenotypes linked to
mutations in this pathway may be due to loss of PI(3,5)P2,
PI5P or both lipids. In addition, disagreement among
studies about whether a specific pathway requires PIKfyve
may be due to differences in the extent of decrease of
PIKfyve activity. In most cell-based studies some PIKfyve
function remains, including mutant cells and RNAi experi-
ments. For example, in PIKfyvebgeo/bgeo MEF cells, 5% of the
normal levels of PIKfyve provide half of the normal levels of
PI(3,5)P2 and PI5P [6]. Here, we present pathways that require
PIKfyve. Those known to be directly regulated by PI(3,5)P2,
because PI(3,5)P2 protein effectors have been identified, will be
indicated. In other cases, the regulatory lipid may either be
PI(3,5)P2 or PI5P.
A. J. McCartney et al. Prospects & Overviews....
56 Bioessays 36: 52–64, 2013 WILEY Periodicals, Inc.
R
e
v
ie
w
e
s
s
a
y
s
Figure 4. A: Localization of PI(3,5)P2 and PI5P inferred from the localization of PIKfyve and Vac14. PI(3,5)P2 localizes on early endosomes,
late endosomes, and lysosomes. Localization of PI(3,5)P2 on autophagosomes is less clear. PI5P may also be present at all or some of these
locations. To further establish the locations of these lipids, suitable lipid probes need to be developed. PI(3,5)P2 effectors and trafficking
pathways affected in PIKfyve/Vac14/Fig4 deficient cells are also indicated. Purple: known PI(3,5)P2 effectors. Blue: proteins affected by
PI(3,5)P2 and/or PI5P. B: The size of a yeast vacuole or mammalian lysosome is dependent on ion and water homeostasis, as well as the net
sum of anterograde traffic, retrograde traffic, membrane fusion, and membrane fission.
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Formation of large vacuoles
A striking feature in PI(3,5)P2 deficient organisms are enlarged
vacuoles [8, 18, 22, 33, 42, 48, 64, 66–68]. In mutant yeast, the
vacuole/lysosome is enlarged. In Vac14/ and Fig4/ MEF
cells, the vacuoles are heterogeneous, arising from both late
endosomes and lysosomes, as well as enlarged autophago-
somes [22, 42, 44, 69]. Complete inhibition of PIKfyve causes
vacuoles to form from early endosomes as well [64].
The enlarged vacuoles in PI(3,5)P2-defective yeast mutants
cannot release water even when exposed to hyperosmotic
shock [5], which suggests an inability to regulate the water
content of the vacuole. Similarly, vacuoles inmammalian cells
are likely due to defects in the regulation of osmolarity within
the endomembrane system. The Vac14ingls/ingls and Fig4/
mouse mutants exhibit extreme hydrocephalus [26, 32], and
the vacuoles that form in Vac14/ or Fig4/ MEF cells are
not filled with lipid [22, 42].
PI(3,5)P2 regulates some ion channels
The defects in water homeostasis may be linked to defects
in ion homeostasis. Indeed, overexpression of the TRPML1
calcium channel in Vac14/ MEF cells suppresses the
formation of vacuoles [61]. In S. pombe, mutations in a
calciumpermease (SPAC521.04c) rescue the enlarged vacuoles
in the fab1D mutant [70]. Suppression in both cases may be
due to regulation of calcium flux.
Table 1. Pathways regulated by Fab1/PIKfyve, Vac14, and Fig4 complex
Pathways affected Known PI(3,5)P2 effectors Species and reference
PI5P biogenesis MTMRsa [6, 111] Cell culture [6, 111]
Vacuole fission Atg18 [37] S. cerevisiae [33, 37]
Retrograde traffic from the vacuole Atg18 [37] S. cerevisiae [37, 79]
Acidification of vacuoles or endolysosomes S. cerevisiae [8, 33]; C. elegans [75];
D. melanogaster [49]; A. thaliana [66];
Ion channel function TRPML1, TRPML2, TRPML3 [61];
TPC1, TPC2, TPC3 [72];
RyR1, RyR2 [62, 73, 112]
Cell culture and mouse [61, 62, 72, 73, 112]
Autophagy in metazoans C. elegans [75]; D. melanogaster [88];
Cell culture [13, 64]; mouse [32, 53, 69, 90]
Fluid phase endocytosis Cell culture [13, 42, 113];
D. melanogaster [49]
Sorting of cargoes at the MVB Vps24a [81] S. cerevisiae (Reviewed in [82])
Traffic of cell surface receptors to lysosomes Cell culture [13]; D. melanogaster [49]
Endosome-to-TGN traffic SNX1, SNX2 [58] Cell culture [13, 42, 48, 58, 85]
Glut4 translocation in response to insulin 3T3 adipocytes (Reviewed in [54])
mTORC1 translocation to the plasma membrane
in response to insulin
Raptor [41] 3T3 adipocytes [41]
Cortical actin array dynamics Formins [60] P. patens [60]
GAL1 induction in the absence of GAL4 pathway Tup1, Cti6 [56] S. cerevisiae [56]
AMPA receptor and Cav1.2 trafficking Neuron culture [44, 100, 101]
Exocytosis Neuron culture [44, 102]
aPotential binding of Vps24 [114] and MTMRs [115] are controversial.
Table 2. Phenotypes of PI(3,5)P2 deficiency in model organisms
Phenotypes Species and reference
Enlarged endosomes and lysosomes S. cerevisiae [1, 8, 9, 33]; S. pombe [16]; C. albicans [74];
cell culture [6, 13, 22, 42, 48, 64, 68]; C. elegans [75];
D. melanogaster [49]; A. thaliana [67]
Sensitivity to heat and calcium S. cerevisiae [8]; S. pombe [16]
Secretion and response to mating hormones S. pombe [16]
Hyphae formation on solid medium C. albicans [74]
Inviable pollen, slow root growth, curled leaves,
dwarfed plants, abnormal flowers
A. thaliana [66, 67]
Stunted growth P. patens [60]
Early lethality C. elegans [75]; D. melanogaster [49];
mouse [6, 14, 22, 26, 42]
Dilute coat color Mouse [22, 26]
Neurodegeneration Mouse [6, 22, 26, 42, 53, 90, 97, 116, 117]
Increased pre- and post-synaptic strength Neuron culture [44]
Myelination defects Mouse [53, 97, 116, 117]
Abnormalities in heart, lung, kidney, thymus, and spleen Mouse [6, 22]
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A role for phosphoinositide regulation of ion channels is better
understood on the plasma membrane where multiple ions
channels are activated by PI(4,5)P2. In some cases, PI(4,5)P2
directly interacts with the channel; in other cases, PI(4,5)P2
recruits regulators [71]. Similarly, PI(3,5)P2 activates ion
channels on endosomes and lysosomes, including mucolipin
transient receptor potential channels (TRPML1, TRPML2,
TRPML3) and yeast homolog, yeast vacuolar conductance
(Yvc1), and two-pore channels (TPC1, TPC2, TPC3) [61, 72].While
the mechanism of PI(3,5)P2 regulation of TPCs is not known,
PI(3,5)P2 interacts directly with the cytoplasmic N-terminus of
TRPML1. PI(3,5)P2 is also important for calcium dynamics in
muscles. PI(3,5)P2 directly activates the ryanodine receptors
(RyR1, RyR2), which release calcium from the sarcoplasmic
reticulum in skeletal and cardiac muscles, respectively [62, 73].
PI(3,5)P2 plays a role in the acidification of the
vacuole
Vacuoles in fab1D, vac7D, and vac14D yeast are less
acidified than wild-type vacuoles [8, 33]. Similar phenotypes
occur in Schizosaccharomyces pombe, Caenorhabditis
elegans, Drosophila melanogaster, and Arabidopsis thali-
ana [49, 66, 74–76]. These acidification defects may contribute
to the formation of large vacuoles; vacuolar ATPase function is
required for both vacuole fission and fusion [77]. However,
PI(3,5)P2 plays additional roles in vacuole morphology. A
limited increase in PI(3,5)P2 corrects acidification of
the vacuole without correcting vacuole size [1, 5]. PI(3,5)P2
effectors involved in acidification have not been identified,
although the vacuolar ATPase is a likely candidate. While
assembly of the vacuolar ATPase does not require PI(3,5)P2 [5],
PI(3,5)P2 may regulate vacuolar ATPase activity.
Fab1/PIKfyve is required for multiple pathways in
the endomembrane system
Membrane trafficking defects also contribute to the formation
of enlarged vacuoles. In yeast, PI(3,5)P2 and Atg18 are required
for fission of the vacuole [38, 78] and retrograde traffic from the
vacuole to the Golgi [37, 79]. These defects contribute to but do
not fully account for the large vacuoles in the fab1D mutant.
The vacuoles in atg18D are not as enlarged as observed in
fab1D yeast [38]. Thus, defects in water and ion homeostasis,
vacuole acidification, as well as defects in membrane
trafficking and vacuole fission, each contribute to the enlarged
vacuoles caused by low levels of PI(3,5)P2 (Fig. 4B).
Roles for Fab1/PIKfyve in the multivesicular body (MVB)
pathway
Fab1/PIKfyve function has been linked to MVB formation, a
protein degradation pathway. MVB formation involves the
ubiquitination and capture of cargoes on the limiting
membrane of late endosomes, which are then internalized
via invagination and formation of intraluminal vesicles (ILVs).
Degradation of protein cargoes occurs when the MVB fuses
with the lysosome. In fab1D yeast, fewer ILVs are formed [1].
Formation of ILVs requires several ESCRT proteins, including
Vps24. While controversial [80], one study suggested that
Vps24 binds PI(3,5)P2 [81]. Thus, the partial defect in ILV
formation may be due to a requirement for PI(3,5)P2 in Vps24
function. In addition to a possible role in forming ILV vesicles,
PI(3,5)P2 may be required for sorting some protein cargoes
(reviewed in [82]). How PI(3,5)P2 regulates cargo sorting
remains to be determined.
Loss of PIKfyve activity has also been linked to events that
occur after cargo sorting. DrosophilaNotch, Wingless and Dpp
(a fly homolog of TGFb) accumulate in the MVB and are not
degraded in a Drosophila fab1 mutant. Thus, Fab1 may also
function downstream of cargo internalization [49]. Delayed
epidermal growth factor receptor (EGFR) degradation due to
inhibition of PIKfyve [64, 83] may also be due to similar
defects: either trafficking problems after sorting ligands into
the MVB or loss of protease activity in lysosomes that are not
properly acidified.
PIKfyve is required for protein trafficking from endosomes to
the trans-Golgi network (TGN)
Similar to yeast [37, 79], PIKfyve is required for retrograde
traffic of proteins from endosomes to the TGN. Knockdown of
PIKfyve inhibits retrograde traffic of the cation-independent
mannose-6-phosphate receptor (CI-MPR), sortillin (a related
receptor) and furin [48]. In Vac14/ fibroblasts [42], or
following inhibition of PIKfyve [13], CI-MPR localizes to
endosomes, and cathepsin D, one of its ligands, is
missorted [42]. Inhibition of PIKfyve also delays trafficking
of the Shiga toxin B-subunit from endosomes to the TGN [13].
These defects may be due in part to misregulation of SNX1
and SNX2, retromer proteins that bind directly to PI(3,5)P2. In
addition, PIKfyve binds to two proteins required for retrograde
trafficking: p40, a Rab9 effector, and JLP, a kinesin adaptor
required for microtubule-based transport from endosomes
to the TGN [84, 85].
Regulation of PIKfyve in response to insulin
PIKfyve is required for insulin-mediated Glut4 translocation.
Insulin stimulates the glucose transporter (Glut4) to tran-
siently translocate to the plasma membrane, which facilitates
glucose uptake. Regulated Glut4 trafficking occurs in both
adipocytes and muscle. Suppression of PIKfyve activity
reduces insulin induced Glut4 translocation in cultured
adipocytes (reviewed in [54]). PIKfyve is also required for
Glut4 trafficking in animals; a muscle-specific knock-out of
PIKfyve in mice causes a defect in Glut4 translocation and
glucose uptake [86]. The precise role(s) of PIKfyve in Glut4
translocation are not known.
Insulin stimulation regulates PIKfyve activity [41, 46, 87],
in part by Akt, which phosphorylates PIKfyve on serine
318 [87]. Moreover, EGF stimulation, which promotes EGFR
internalization and degradation, also induces Akt phosphor-
ylation of PIKfyve on serine 318 [83]. However, in cells the
degree of activation of PIKfyve due to phosphorylation of
serine 318 is relatively modest. Thus, there are may be
additional Akt phosphorylation sites on PIKfyve, as well as
additional PIKfyve activators.
One outcome of insulin activation of PIKfyve in adipocytes
is an effect on mTOR, a major regulator of cell metabolism.
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Insulin-induced translocation of mTOR to the plasma
membrane, as well as mTOR activity, requires PIKfyve [41].
The recruitment of mTOR to the plasma membrane in
response to insulin may occur through direct interactions
with PI(3,5)P2. However, whether PI(3,5)P2 is found on the
plasma membrane of adipocytes is not known.
Fab1/PIKfyve is required for autophagy in metazoans
Autophagy requires Fab1/PIKfyve. Autophagy delivers car-
goes to the lysosome for degradation. Suppression of Fab1/
PIKfyve results in impaired clearance of autophagic organ-
elles. In C. elegans, mutations in PPK-3 (Fab1) cause an
increase in autophagosomes [75]. Similarly, Drosophila fab1
mutant larvae accumulate autophagosomes and amphi-
somes [88]. In NIH3T3 or HEK293 cells, and in primary
cultured hippocampal neurons, inhibition of PIKfyve with
YM201636 or MF4 causes an accumulation of autophagosomes
and the autophagic marker, LC3-II [13, 64, 89]. Similarly, the
brains of mice with mutations in Fig4 have elevated levels of
LC3-II and p62, another marker of autophagy [32, 53, 69, 90].
Together, the above studies indicate that PIKfyve has multiple
roles in the endomembrane system.
Roles for lysosomal PI(3,5)P2 in the regulation of transcription
Endosomal PI(3,5)P2 may also regulate some transcriptional
pathways. Expression of pheromone-responsive genes in
S. pombe is defective in a fab1D mutant [16]. Similarly,
in S. cerevisiae PI(3,5)P2 modulates transcription via interac-
tion with Tup1 and Cti6 [56]. PI(3,5)P2 provides a site on
the yeast vacuole for assembly of the Tup1/Cyc8/Cti6
transcription complex. These findings predict that PI(3,5)P2
on lysosomesmay regulate additional transcription pathways.
Fab1/PIKfyve may function at the plasma membrane
In addition to multiple functions on endosomes, a small pool
of Fab1/PIKfyve may function at or near the plasma
membrane. In adipocytes, PIKfyve activity may contribute
to localization of mTORC1 to the plasma membrane.
Furthermore, PIKfyve has been implicated in phagocytosis
and pinocytosis [91, 92]. Further evidence for a potential role
for Fab1/PIKfyve at the plasma membrane comes from the
Physcomitrella patens class II formins, which bind PI(3,5)
P2 [60] and require Fab1 activity for their localization at the cell
cortex. PIKfyve has also been implicated in actin remodeling
in mammalian cells (reviewed in [54]). In addition, when
expressed heterologously in Xenopus oocytes, several plasma
membrane localized ion channels and carrier proteins require
PIKfyve activity (reviewed in [54, 82, 93]). Thus, while most
PIKfyve is associated with endosomal membranes, PIKfyve
may also have roles at the plasma membrane.
Fab1/PIKfyve, Vac14, and Fig4 in plant
and animal physiology
PIKfyve plays critical roles in development. Knockout of
PIKfyve in mice results in very early lethality: PIKfyve/
embryos did not survive past E3.5 [14] and, in an independent
knock-out, embryos did not survive past E8.5 [18]. Similarly,
Drosophila fab1 and C. elegans (ppk-3) mutants display
early lethality [49, 75]. In Arabidopsis thaliana the two Fab1
genes, FAB1A and FAB1B, play critical roles in develop-
ment [66, 67], perhaps due in part to hyposensitivity to auxin
signaling [94].
Analysis of a PIKfyvebgeo/bgeo hypomorphic mutant mouse
with partial PIKfyve activity, which dies perinatally, has
revealed post-development roles of PI(3,5)P2 and PI5P in animal
physiology [6]. Similarly, Vac14/ mutant mice, which also
have less Fig4 protein [6, 32], die perinatally [42]. Fig4/ mice
can live up to six weeks [22]. Vac14ingls/ingls, a missense
mutation that disrupts binding of Vac14 with PIKfyve, survives
up to three weeks [26]. Differences in lethality may be largely
due to differences in strain background. Early lethality is
rescued in Fig4/mice by neuronal-specific, but not astrocyte-
specific, expression of Fig4 [95]. Thus, loss of PI(3,5)P2 and PI5P
in neurons likely contributes to early lethality of the Fig4/
mice and other PIKfyve-related mouse models.
Multiple tissues require PIKfyve
Vac14, Fig4, and PIKfyve are expressed globally. Accordingly,
defects in the corresponding mouse mutants occur in multiple
tissues. Hearts of the Vac14/, Fig4/, and PIKfyve
hypomorph mutants have vacuoles [6] and in the two latter
mutants, there is a spongiform-like phenotype in the spleen
as well. Moreover, the lungs and kidneys of the PIKfyve
hypomorph have a spongiform-like appearance. Conditional
knock-out of PIKfyve (PIPKIII), in intestinal cells, causes
vacuole formation and defects in membrane trafficking in the
gut epithelia, which ultimately lead to early lethality [18].
Vac14, PIKfyve, and Fig4 proteins are most abundant in
the nervous system, which fits with findings that the nervous
system is profoundly affected in the corresponding mutant
animals [6, 44]. Fig4/, Vac14/, and Vac14ingls/ingls mice
display degeneration of the brain, including enlarged
ventricles, increased apoptosis and severe spongiform
encephalopathy; large vacuoles in the cell bodies of
neurons are also observed in the peripheral nervous
system [22, 26, 42]. The PIKfyve hypomorph has similar
defects [6]. Consistent with the importance of PI(3,5)P2 and
PI5P in the nervous system, a mouse with a neuron-specific
knock-out of Vps34, displays juvenile lethality and neuro-
degeneration, and has reduced PI3P and PI(3,5)P2. PI5P was
not measured [96].
Myelination is reduced in the central and peripheral
nerves of Fig4/ mice [22, 95, 97]. Fig4 may be particularly
abundant during development of myelinating cells and dorsal
root ganglia sensory neurons [98], although Fig4/ controls,
which would indicate whether the antigen detected by
the anti-Fig4 antibody was bona fide Fig4, were missing.
Interestingly, hypomyelination in Fig4/ mice is rescued
by neuron-specific expression of Fig4 [97]. Heterozygous
Fig4þ/ mice show no signs of neurodegeneration or
increased susceptibility to trauma-induced degeneration [99].
Mtmr2/Fig4/ double mutant mice have more severe
hypomyelination and neurodegeneration, which suggest that
loss of PI5P contributes to these phenotypes [53].
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PIKfyve in neurons
Vac14, PIKfyve, and Fig4 have specialized roles at the
synapse. AMPA-type glutamate receptors, which mediate fast
neurotransmission in the brain, cycle between endosomes and
the plasma membrane. Notably, trafficking of the AMPA
receptor subunits, GluA1 and GluA2, is modulated by the
PIKfyve complex. shRNA silencing of PIKfyve impairs
trafficking of GFP-HA-GluA2 [100], and addition of PI(3,5)P2
promotes trafficking of heterologously expressed GluA1 [101].
In Vac14/ cultured hippocampal neurons, GluA1 and GluA2
are increased on the plasma membrane with a concomitant
increase in postsynaptic strength [44]. Similarly, in cultured
cortical neurons, internalization and degradation of the
L-type voltage-gated calcium channel subunit, CaV1.2,
requires PIKfyve [100].
In addition to postsynaptic defects, Vac14/ neurons also
displayed an increased probability of presynaptic vesicle
fusion [44]. Similarly, PIKfyve is a negative regulator of
calcium-dependent exocytosis in neurosecretory cells [102].
Together, PIKfyve and potentially PI(3,5)P2, PI5P or both
negatively regulate the excitatory response of neurons, which
may explain why defects in the PIKfyve complex are linked
to excitotoxic neuronal death.
Further determination of roles for PI(3,5)P2 and PI5P
signaling at the synapse will likely come from identification of
proteins that bind these lipids and/or interact with the Vac14,
PIKfyve, or Fig4. Potential candidates include clavesin and
nitric oxide synthase (nNOS). Clavesin (clathrin vesicle-
associated Sec14 protein), is expressed solely in the brain
and binds PI(3,5)P2. Knockdown of clavesin causes enlarged
late-endosomes/lysosomes similar to those seen with sup-
pression of PIKfyve activity [59]. nNOS, which functions at the
synapse in the regulation of neurotransmission, binds Vac14
through a PDZ domain in vitro [103]; a functional interaction
between Vac14 and nNOS at the synapse has not been tested.
Mutations in genes that encode the
Vac14, PIKfyve, and Fig4 complex
associated with human diseases
Mutations in FIG4 underlie a severe form Charcot-Marie-Tooth
(CMT) type 4J [22] (Table 3). In CMT, progressive deterioration
of nerves and/or demyelination throughout the peripheral
nervous system results in reduced nerve conduction velocity
and sensory sensation. These defects overlap with those
observed in the Fig4/ mouse. The most common genotype
in CMT4J patients is FIG4 compound heterozygosity:
one null allele and the other encoding the missense mutation,
isoleucine 41 to threonine (I41T) [22]. The mutation retains
partial function. In Fig4/ mice, overexpression of a
Fig4-I41T transgene significantly suppresses the early
lethality [22, 32]. That Fig4-I14T has a modest functional
defect, yet causes peripheral neuropathy, underscores the
importance of precise modulation of PI(3,5)P2 and/or PI5P
levels in the nervous system.
CMT4B1 and CMT4B2 are caused by loss-of-function
mutations in MTMR2 and MTMR13, respectively (reviewed
in [104]) and have clinical symptoms that overlap with those
observed in CMT4J. The clinical symptoms in common
between CMT4B and CMT4J may be due to either less PI5P
or elevated PI3P.
A range of mutations in FIG4 was found in seven out
of 473 patients with amyotrophic lateral sclerosis (ALS)
and two patients with PLS [105]. Mutations in FIG4 may
be causative in other neurological diseases as well.
Moreover, mutations in FIG4 can cause defects in
additional tissues. Homozygous null mutations in FIG4
cause Yunis-Varo´n syndrome, a severe autosomal-recessive
congenital disorder, which affects multiple tissues,
including the heart, skeletal muscle, skeleton and brain
[106]. The diversity of affected tissues underscores the
importance of the Vac14, Fig4 and PIKfyve complex in
human physiology.
To date, neither PIKfyve nor Vac14 have been linked
to neurological disease. Heterozygous null mutations in
PIKfyve are associated with Francois-Mouchetee Fleck
Corneal Dystrophy (CFD) [107], which results in white
flecks throughout the corneal stroma of the eye that do
not affect vision. Corneal flecks are thought to be enlarged
vacuoles in swollen keratocytes [108]. Interestingly, Vac14
mRNA is downregulated in a large subset of patients with
chronic fatigue syndrome [109]. Based on the common
molecular functions of PIKfyve, Vac14, and Fig4, it is
tempting to speculate that mutations in PIKfyve and
Vac14 will be discovered that are linked to neurological
disorders.
Table 3. Human disease
Disease Affected gene Reference
Charcot-Marie-Tooth type 4J (CMT4J) Fig4 I41Ta
Fig4 L17Pa
[22, 105, 116]
Amyotrophic lateral sclerosis (ALS) Mutations in Fig4 [105]
Primary lateral sclerosis (PLS) Mutations in Fig4 [105]
Yunis–Varon syndrome Mutations in Fig4 [106]
Charcot-Marie-Tooth type 4B1 Mutations in MTMR2 Reviewed in [104]
Charcot-Marie-Tooth type 4B2 Mutations in MTMR13 Reviewed in [104]
Francois-Mouchetee Fleck Corneal Dystrophy Mutations in PIKfyve [107, 108]
Chronic Fatigue Syndrome Down regulation of Vac14 [109]
aPatients are compound heterozygotes with a null allele of Fig4 and Fig4-I41T, or Fig4-L17P.
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Conclusions
The roles and regulation of PI(3,5)P2 parallel those of other PIP
species. Notably, PI3P is a precursor for PI(3,5)P2, which in
turn is a precursor for PI5P. The interconversion between
these lipids predicts that there are pathways where these
lipids spatially and temporally control multi-step pathways.
Compared with PI3P, PI4P, and PI(4,5)P2, the levels of
PI(3,5)P2 are exceedingly low. The difficulty of measuring the
low levels of PI(3,5)P2 in cells, and the lack of a fluorescent
probe to monitor its spatial and temporal dynamics have
provided major hurdles toward elucidating the roles and
regulation of PI(3,5)P2. A more complete picture of the
pathways that rely on PI(3,5)P2 and PI5P will likely provide
insights into how minor defects in the regulation of these
lipids leads to profound human diseases. Recent observations
that mutations in Fig4 cause defects with striking similarities
to lysosomal storage disorders may also provide insight into
the links between these lipids and disease [110]. Moreover, as
whole exome sequencing of patients becomes feasible, more
diseases linked to this pathway will likely be discovered. The
severity of CMT4J, ALS and Yunis-Varon syndrome under-
scores the importance of uncovering the molecular mecha-
nisms that regulate the Vac14/PIKfyve/Fig4 complex, as well
as the discovery of new cellular pathways that are regulated
by PI(3,5)P2 and PI5P.
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